Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BioNTech SE Sponsored ADR (BNTX) vs Roivant Sciences Ltd. (ROIV)

BioNTech SE Sponsored ADR and Roivant Sciences Ltd. are both Biotechnology companies. BioNTech SE Sponsored ADR and Roivant Sciences Ltd. are of similar size ($25.6B and $24.9B). BioNTech SE Sponsored ADR grew revenue faster over the last twelve months: −3.33% against −67.6%. BioNTech SE Sponsored ADR has the higher net margin (−65.8% vs −3,535.0%) and the lower return on invested capital (−38.4% vs −34.5%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 10 and Roivant Sciences Ltd. on 8.

Valuation

Metric BNTX ROIV Biotechnology median
P/E n/m n/m 7.88
P/S 8.27 3,425.89 11.47
P/B 1.21 5.24 2.52
Price to free cash flow 49.85 n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.70 2,958.77 10.73
Earnings yield (7.95%) (1.06%) (28.84%)
Free cash flow yield 2.01% (3.18%) (23.03%)

Profitability

Metric BNTX ROIV Biotechnology median
Gross margin 75.24% 81.21% 65.16%
Operating margin (77.94%) (7,914.75%) 0.00%
Net margin (65.75%) (3,534.96%) 0.00%
Free cash flow margin 16.58% (10,901.00%) 0.00%
Return on equity (9.53%) (5.47%) (57.72%)
Return on assets (8.24%) (5.15%) (49.22%)
Return on invested capital (38.39%) (34.51%) 0.00%

Growth

Metric BNTX ROIV Biotechnology median
Revenue growth (TTM) (3.33%) (67.58%) 5.64%
EPS growth (last fiscal year) (77.33%) (125.00%) —
Revenue growth, 5-year CAGR 42.58% (19.07%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX ROIV Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 7.85 16.72 4.73
Net debt to EBITDA 14.29 8.39 0.96

Dividend

Metric BNTX ROIV Biotechnology median
Dividend yield 1.33% — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BNTX ROIV Biotechnology median
Market cap 24.94b 25.64b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack